AKRO
Price
$40.94
Change
-$1.01 (-2.41%)
Updated
Apr 3, 02:28 PM (EDT)
Capitalization
3.34B
47 days until earnings call
ETNB
Price
$6.93
Change
-$0.26 (-3.62%)
Updated
Apr 3, 02:37 PM (EDT)
Capitalization
1.05B
34 days until earnings call
Ad is loading...

AKRO vs ETNB

Header iconAKRO vs ETNB Comparison
Open Charts AKRO vs ETNBBanner chart's image
Akero Therapeutics
Price$40.94
Change-$1.01 (-2.41%)
Volume$200
Capitalization3.34B
89bio
Price$6.93
Change-$0.26 (-3.62%)
Volume$822
Capitalization1.05B
AKRO vs ETNB Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. ETNB commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and ETNB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (AKRO: $41.95 vs. ETNB: $7.19)
Brand notoriety: AKRO and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 114% vs. ETNB: 70%
Market capitalization -- AKRO: $3.34B vs. ETNB: $1.05B
AKRO [@Biotechnology] is valued at $3.34B. ETNB’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than ETNB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish while ETNB’s TA Score has 4 bullish TA indicator(s).

  • AKRO’s TA Score: 4 bullish, 5 bearish.
  • ETNB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than ETNB.

Price Growth

AKRO (@Biotechnology) experienced а -3.10% price change this week, while ETNB (@Biotechnology) price change was -10.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.32%. For the same industry, the average monthly price growth was -10.36%, and the average quarterly price growth was -14.47%.

Reported Earning Dates

AKRO is expected to report earnings on May 20, 2025.

ETNB is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.34B) has a higher market cap than ETNB($1.05B). AKRO YTD gains are higher at: 50.791 vs. ETNB (-8.056). AKRO has higher annual earnings (EBITDA): -247.37M vs. ETNB (-361.06M). AKRO has more cash in the bank: 743M vs. ETNB (440M). AKRO (36.5M) and ETNB (37.5M) have identical debt. AKRO (0) and ETNB (0) have equivalent revenues.
AKROETNBAKRO / ETNB
Capitalization3.34B1.05B318%
EBITDA-247.37M-361.06M69%
Gain YTD50.791-8.056-630%
P/E RatioN/AN/A-
Revenue00-
Total Cash743M440M169%
Total Debt36.5M37.5M97%
TECHNICAL ANALYSIS
Technical Analysis
AKROETNB
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
66%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 23 days ago
83%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JARSX14.800.14
+0.95%
Easterly Global Real Estate R6
TIBAX27.650.02
+0.07%
Thornburg Investment Income Builder A
VICEX21.87N/A
N/A
USA Mutuals Vice Investor
IARRX17.15N/A
N/A
Invesco Real Estate R
BREIX37.47N/A
N/A
Baron Real Estate Institutional

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+8.57%
ETNB - AKRO
57%
Loosely correlated
+5.81%
SLS - AKRO
39%
Loosely correlated
N/A
VTYX - AKRO
38%
Loosely correlated
-0.93%
MDGL - AKRO
37%
Loosely correlated
+3.28%
TRDA - AKRO
36%
Loosely correlated
+0.46%
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+5.81%
AKRO - ETNB
58%
Loosely correlated
+8.57%
RCKT - ETNB
51%
Loosely correlated
+8.43%
IDYA - ETNB
49%
Loosely correlated
+10.70%
NTLA - ETNB
48%
Loosely correlated
+9.69%
DNLI - ETNB
47%
Loosely correlated
+11.80%
More